
What happened
Oppenheimer Holdings Inc. (NYSE: OPY) said third-quarter net income fell to $5.5 million from $21.7 million a year earlier. Diluted earnings per share were $0.47, down 75.3% from $1.90. Revenue fell 10.0% to $382.0 million from $424.4 million.
Capital Markets swung to a pre-tax loss of $9.9 million from income of $12.3 million. Equities underwriting fees fell 82.0% on fewer transactions. Fixed income sales and trading revenue fell 23.8%.
Wealth Management revenue rose 2.5% to $266.2 million. Advisory fees climbed 15.3% on higher average assets under management (AUM). AUM reached a record $59.6 billion at Sept. 30. Retail commissions fell 13.9% on lower trading activity.
A $21.0 million pre-tax expense on a long-term incentive program for financial advisors also weighed on results. The program is tied to the OPY stock price, which rose from $105.54 to $117.96 during the quarter. Oppenheimer changed the program formula in 2026 to reduce grants, but the full effect will take several years.
Key numbers
| Metric | Latest | Change | Source |
|---|---|---|---|
| Diluted EPS, Q3 | $0.47 | from $1.90, -75.3% | Oppenheimer Q3 2026 earnings release (SEC 8-K Ex. 99.1) |
| Revenue, Q3 | $382.0 million | from $424.4 million, -10.0% | Oppenheimer Q3 2026 earnings release (SEC 8-K Ex. 99.1) |
| Net income attributable to Oppenheimer, Q3 | $5.5 million | from $21.7 million, -74.9% | Oppenheimer Q3 2026 earnings release (SEC 8-K Ex. 99.1) |
| Net margin, Q3 | 1.4% | from 5.1%, -3.7 percentage points | Calculated from SEC 8-K |
| Wealth Management AUM at Sept. 30 | $59.6 billion | from $55.1 billion, +$4.5 billion | Oppenheimer Q3 2026 earnings release (SEC 8-K Ex. 99.1) |
| Capital Markets pre-tax result, Q3 | -$9.9 million | from $12.3 million | Oppenheimer Q3 2026 earnings release (SEC 8-K Ex. 99.1) |
Read more: Oppenheimer (OPY) company research
Why it matters
OptimistFi calculates that net margin narrowed from 5.1% to 1.4%, about 3.7 percentage points, because net income fell faster than revenue. Adjusted net income, a non-GAAP measure that leaves out the incentive expense, was $20.9 million against $31.7 million a year earlier. Earnings fell even without it.
OptimistFi has argued that Oppenheimer builds value from fee-bearing wealth management assets and higher-margin capital markets work. This quarter supports only the first half, so the view is mixed. Advisory fees grew, but Capital Markets lost money.
The record AUM comes with caveats. The $4.5 billion rise from a year earlier combined $6.2 billion of higher asset values on existing holdings with $1.7 billion of net distributions. Wealth Management pre-tax income still fell 11.0% to $55.6 million.
CEO Robert S. Lowenthal called earnings disappointing. He pointed to lower retail trading, reduced investment banking volumes and the stock-linked expense. Stockholders' equity reached a record $991.1 million.
Stock perps: every US stock that trades as a perpetual future, by leverage, live
What's next
The board declared a quarterly dividend of $0.20 per share, payable Nov. 27 to holders of record Nov. 13.
The next quarterly report will show whether Capital Markets returns to profit and whether the lower grant count begins to trim the stock-linked incentive expense.
More from OptimistFi
From OptimistFi Perps
- Top perps movers today: stocks, commodities, FX and indices
- Open interest live: crypto and stock perps by exchange
- All perp markets: price, open interest and funding by venue
- Futures calculator: liquidation price, PnL and fees by exchange
- Perp funding rates live: what longs and shorts pay on every venue
Sources
- Oppenheimer Holdings Inc. Reports Third Quarter 2026 Earnings (SEC EDGAR 8-K, Item 2.02, Exhibit 99.1) — Earnings release dated Oct. 30, 2026 with results, segment tables, non-GAAP reconciliation and dividend declaration.
Explore OptimistFi research on Oppenheimer Holdings Inc.: https://optimistfi.com/stocks/OPY
Browse Oppenheimer Holdings Inc. company coverage and explore the OptimistFi Thesis-Break Engine.
Browse every company OptimistFi covers at optimistfi.com/stocks, or read the latest evidence-first research.
Find available research on the Oppenheimer Holdings Inc. company page.
Originally published on OptimistFi, evidence-first equity research. More at optimistfi.com.
